UTP is not a biased agonist at human P2Y11 receptors

Morrow, Gael B. and Nicholas, Robert A. and Kennedy, Charles (2014) UTP is not a biased agonist at human P2Y11 receptors. Purinergic Signalling, 10 (4). pp. 581-585. ISSN 1573-9538 (https://doi.org/10.1007/s11302-014-9418-3)

[thumbnail of Morrow-etal-PS-2014-UTP-is-not-a-biased-agonist-at-human]
PDF. Filename: Morrow_etal_PS_2014_UTP_is_not_a_biased_agonist_at_human.pdf
Accepted Author Manuscript

Download (646kB)| Preview


Biased agonism describes a multi-state model of G protein-coupled receptor activation in which each ligand induces a unique structural conformation of the receptor, such that the receptor couples differentially to G proteins and other intracellular proteins. P2Y receptors are G protein-coupled receptors that are activated by endogenous nucleotides, such as ATP and UTP. A previous report suggested that UTP may be a biased agonist at the human P2Y11 receptor, as it increased cytosolic [Ca2+], but did not induce accumulation of inositol phosphates, whereas ATP did both. The mechanism of action of UTP was unclear, so the aim of this study was to characterise the interaction of UTP with the P2Y11 receptor in greater detail. Intracellular Ca2+ was monitored in 1321N1 cells stably expressing human P2Y11 receptors using the Ca2+-sensitive fluorescent indicator, fluo-4. ATP evoked a rapid, concentration-dependent rise in intracellular Ca2+, but surprisingly, even high concentrations of UTP were ineffective. In contrast, UTP was slightly, but significantly more potent than ATP in evoking a rise in intracellular Ca2+ in 1321N1 cells stably expressing the human P2Y2 receptor, with no difference in the maximum response. Thus the lack of response to UTP at hP2Y11 receptors was not due to a problem with the UTP solution. Furthermore, coapplying a high concentration of UTP with ATP did not inhibit the response to ATP. Thus contrary to a previous report, we find no evidence for an agonist action of UTP at the human P2Y11 receptor, nor does UTP act as an antagonist.